findmyKOL
Clinical trialNCT00003126CompletedPhase 3Interventional

Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer

SponsorLoyola UniversityEnrollment69Kidney Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Cancer Center and Beckman Research Institute, City of Hope

    Duarte, California, United States

  • Jonsson Comprehensive Cancer Center, Ucla

    Los Angeles, California, United States

  • Usc/norris Comprehensive Cancer Center and Hospital

    Los Angeles, California, United States

  • Summit Medical Center

    Oakland, California, United States

  • Loyola University Medical Center

    Maywood, Illinois, United States

  • Indiana University Cancer Center

    Indianapolis, Indiana, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michigan, United States

  • Barbara Ann Karmanos Cancer Institute

    Detroit, Michigan, United States

  • Norris Cotton Cancer Center

    Lebanon, New Hampshire, United States

  • Our Lady of Mercy Medical Center

    The Bronx, New York, United States

  • Carolinas Medical Center

    Charlotte, North Carolina, United States

  • Earle A. Chiles Research Institute at Providence Portland Medical Center

    Portland, Oregon, United States

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, United States

  • University of Texas Health Science Center at San Antonio

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 1997
Primary completion
31 Aug 2002
Completion
31 Aug 2002
Last update posted
4 Jan 2017
Registered enrollment
69
Registry id
NCT00003126

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.